Quest CDM | Home

Help in meeting your testing needs from a lab you can trust

When in-office testing is not an option, Quest Diagnostics Patient Service Centers can provide the drug monitoring services you need.

Why drug testing matters

Drug misuse can happen to anyone, regardless of income or status. In the latest Health Trends report, 51% of test results were inconsistent with their prescribed medication regimen.

Drug testing during the COVID-19 pandemic

The pandemic presents difficult challenges to providing appropriate levels of drug monitoring for opioids and other prescription drugs. Together, we can ensure your patients get the treatment they need.

Mastering the conversation

Drug monitoring can be a sensitive topic for clinicians and patients alike. Learn more about how to approach the topic with patients.

Primary Care Clinician

Helping to protect your patients and your practice

Pain Specialists

Helping to ensure patient compliance

Behavioral Health

Timely insights to inform clinical decisions

Health Systems

Balancing clinical benefit with cost

See how inconsistent drug test results compare in your state

2019 Health Trends data now available!

An interactive state-by-state overview of patient compliance and inconsistent results

Our industry-leading toxicology experts are available to help you with results interpretation.

Give them a call today! 1.877.40.RXTOX 1.877.407.9869

State monitors now available

Select the state to download an overview of an individual state’s opioid prescription guidelines

2020 Health Trends Study

Now Available! The Quest Diagnostics Health Trends™ study, published in the journal Population Health Management, compared testing rates and results from across the country before and after the onset of the pandemic.

Check this out!

Now available, Topics in Drug Testing, a new podcast series from the Quest Diagnostics drug monitoring expert

Click here to listen now or download for later.

Our Blog

Helping you stay current in drug monitoring

Full-Spectrum CBD May Trigger Positive THC Result

Use of so-called “full-spectrum” formulations of cannabidiol (CBD) products can cause users to test positive for THC, the component of marijuana that causes euphoria, according to an open-label study published in JAMA Psychiatry.

Rely on a trusted lab dedicated to responsible testing

With over 50 years of expertise in diagnostic testing, Quest Diagnostics has been providing insights that can lead to more informed decisions. Our drug testing solutions and approach are making a difference in cost and patient care.

Quest Diagnostics Clinical Drug Monitoring